Prenatal infection, maternal immune activation, and risk for schizophrenia

Translational Neuroscience

Volumn 3, Issue 4, 2012, Pages 320-327

  Canetta, Sarah E ^a   Brown, Alan S ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b New York State Psychiatric Institute ^*  (United States)

Author keywords

Cytokines; Maternal immune activation; Neurodevelopment; Polyinosinic polycytosinic acid (Poly IC); Prenatal infection; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BACTERIUM LIPOPOLYSACCHARIDE; CILIARY NEUROTROPHIC FACTOR; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; DOPAMINE; EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEU DIFFERENTIATION FACTOR; NUCLEAR RECEPTOR RELATED FACTOR 1; POLYINOSINIC POLYCYTIDYLIC ACID; SEROTONIN; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY TITER; ARTICLE; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; CELL ACTIVATION; CYTOKINE PRODUCTION; DISC1 GENE; DISEASE MODEL; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLUENZA; INTRAUTERINE INFECTION; MEDICAL LITERATURE; MEDICAL RESEARCH; MICROGLIA; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMITTER RELEASE; NONHUMAN; NURR1 GENE; PREGNANCY; PRENATAL EXPOSURE; PREPULSE INHIBITION; PRIMATE; PRIORITY JOURNAL; PROGENY; PSYCHOSIS; RISK ASSESSMENT; RODENT; SCHIZOPHRENIA; TOXOPLASMA GONDII; TOXOPLASMOSIS; WHITE MATTER INJURY;

EID: 84871436061     PISSN: 20813856     EISSN: 20816936     Source Type: Journal    
DOI: 10.2478/s13380-012-0045-6     Document Type: Article

References (74)

1. Marenco S., Weinberger D.R., The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev. Psychopathol., 2000, 12, 501-527
2. Brown A. S., Derkits E. J., Prenatal infection and schizophrenia: a review of epidemiologic and translational studies, Am. J. Psychiatry, 2010, 167, 261-280
3. Brown A. S., Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism, Dev. Neurobiol., 2012, 72, 1272-1276
4. Patterson P. H., Immune involvement in schizophrenia and autism: etiology, pathology and animal models, Behav. Brain Res., 2009, 204, 313-321
5. Boksa P., Effects of prenatal infection on brain development and behavior: a review of findings from animal models, Brain Behav. Immun., 2010, 24, 881-897
6. Mednick S. A., Machon R. A., Huttunen M. O., Bonett D., Adult schizophrenia following prenatal exposure to an influenza epidemic, Arch. Gen. Psychiatry, 1988, 45, 189-192 (Pubitemid 18052851)
7. Barr C. E., Mednick S. A., Munk-Jorgensen P., Exposure to influenza epidemics during gestation and adult schizophrenia. A 40-year study, Arch. Gen. Psychiatry, 1990, 47, 869-874 (Pubitemid 20302703)
8. O'Callaghan E., Sham P., Takei N., Glover G., Murray R. M., Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic, Lancet, 1991, 337, 1248-1250
9. Sham P. C., O'Callaghan E., Takei N., Murray G. K., Hare E. H., Murray R. M., Schizophrenia following pre-natal exposure to influenza epidemics between 1939 and 1960, Br. J. Psychiatry, 1992, 160, 461-466
10. Selten J. P. Slaets J. P., Evidence against maternal influenza as a risk factor for schizophrenia, Br. J. Psychiatry, 1994, 164, 674-676 (Pubitemid 24161267)
11. Susser E., Lin S. P., Brown A. S., Lumey L. H., Erlenmeyer-Kimling L., No relation between risk of schizophrenia and prenatal exposure to influenza in Holland, Am. J. Psychiatry, 1994, 151, 922-924
12. Erlenmeyer-Kimling L., Folnegovic Z., Hrabak-Zerjavic V., Borcic B., Folnegovic-Smalc V., Susser E., Schizophrenia and prenatal exposure to the 1957 A2 influenza epidemic in Croatia, Am. J. Psychiatry, 1994, 151, 1496-1498 (Pubitemid 24301696)
13. Morgan V., Castle D., Page A., Fazio S., Gurrin L., Burton P., et al., Influenza epidemics and incidence of schizophrenia, affective disorders and mental retardation in Western Australia: no evidence of a major effect, Schizophr. Res., 1997, 26, 25-39 (Pubitemid 27372055)
14. Brown A. S., Begg M. D., Gravenstein S., Schaefer C. A., Wyatt R. J., Bresnahan M., et al., Serologic evidence of prenatal influenza in the etiology of schizophrenia, Arch. Gen. Psychiatry, 2004, 61, 774-780 (Pubitemid 39031117)
15. Brown A. S., Schaefer C. A., Quesenberry C. P. Jr., Liu L., Babulas V. P., Susser E. S., Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring, Am. J. Psychiatry, 2005, 162, 767-773 (Pubitemid 40489141)
16. Mortensen P. B., Norgaard-Pedersen B., Waltoft B. L., Sorensen T. L., Hougaard D., Torrey E. F., et al., Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth, Biol. Psychiatry, 2007, 61, 688-693 (Pubitemid 46328861)
17. Buka S. L., Tsuang M. T., Torrey E. F., Klebanoff M. A., Bernstein D., Yolken R. H., Maternal infections and subsequent psychosis among offspring, Arch. Gen. Psychiatry, 2001, 58, 1032-1037 (Pubitemid 33051828)
18. Buka S. L., Cannon T. D., Torrey E. F., Yolken R. H., Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring, Biol. Psychiatry, 2008, 63, 809-815 (Pubitemid 351400765)
19. Brown A. S., Schaefer C. A., Quesenberry C. P. Jr., Shen L., Susser E. S., No evidence of relation between maternal exposure to herpes simplex virus type 2 and risk of schizophrenia?, Am. J. Psychiatry, 2006, 163, 2178-2180 (Pubitemid 46114240)
20. Brown A. S., Cohen P., Greenwald S., Susser E., Nonaffective psychosis after prenatal exposure to rubella, Am. J. Psychiatry, 2000, 157, 438-443 (Pubitemid 30145931)
21. Sorensen H. J., Mortensen E. L., Reinisch J. M., Mednick S. A., Association between prenatal exposure to bacterial infection and risk of schizophrenia, Schizophr. Bull., 2009, 35, 631-637
22. Crow T. J., Done D. J., Prenatal exposure to influenza does not cause schizophrenia, Br. J. Psychiatry, 1992, 161, 390-393
23. Cannon M., Cotter D., Coffey V. P., Sham P. C., Takei N., Larkin C., et al., Prenatal exposure to the 1957 influenza epidemic and adult schizophrenia: a follow-up study, Br. J. Psychiatry, 1996, 168, 368-371
24. Brown A. S., Vinogradov S., Kremen W. S., Poole J. H., Deicken R. F., Penner J. D., et al., Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia, Am. J. Psychiatry, 2009, 166, 683-690
25. Brown A. S., Vinogradov S., Kremen W. S., Poole J. H., Bao Y., Kern D., et al., Association of maternal genital and reproductive infections with verbal memory and motor deficits in adult schizophrenia, Psychiatry Res., 2011, 188, 179-186
26. Brown A. S., Deicken R. F., Vinogradov S., Kremen W. S., Poole J. H., Penner J. D., et al., Prenatal infection and cavum septum pellucidum in adult schizophrenia, Schizophr. Res., 2009, 108, 285-287
27. Brown A. S., Hooton J., Schaefer C. A., Zhang H., Petkova E., Babulas V., et al., Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring, Am. J. Psychiatry, 2004, 161, 889-895 (Pubitemid 38625343)
28. Buka S. L., Tsuang M. T., Torrey E. F., Klebanoff M. A., Wagner R. L., Yolken R. H., Maternal cytokine levels during pregnancy and adult psychosis, Brain Behav. Immun., 2001, 15, 411-420 (Pubitemid 34044524)
29. Ellman L. M., Deicken R. F., Vinogradov S., Kremen W. S., Poole J. H., Kern D. M., et al., Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8, Schizophr. Res., 2010, 121, 46-54
30. Fatemi S. H., Emamian E. S., Kist D., Sidwell R. W., Nakajima K., Akhter P., et al., Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice, Mol. Psychiatry, 1999, 4, 145-154 (Pubitemid 29163977)
31. Shi L., Fatemi S. H., Sidwell R. W., Patterson P. H., Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring, J. Neurosci., 2003, 23, 297-302 (Pubitemid 36050430)
32. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., et al., The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology, J. Neurosci., 2006, 26, 4752-4762 (Pubitemid 44315314)
33. Fortier M. E., Joober R., Luheshi G. N., Boksa P., Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamineinduced locomotion and startle responses in adult rat offspring, J. Psychiatr. Res., 2004, 38, 335-345 (Pubitemid 38299172)
34. Smith S. E., Li J., Garbett K., Mirnics K., Patterson P. H., Maternal immune activation alters fetal brain development through interleukin-6, J. Neurosci., 2007, 27, 10695-10702 (Pubitemid 47535869)
35. Kumral A., Baskin H., Yesilirmak D. C., Ergur B. U., Aykan S., Genc S., et al., Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain, Neonatology, 2007, 92, 269-278 (Pubitemid 350125285)
36. Makinodan M., Tatsumi K., Manabe T., Yamauchi T., Makinodan E., Matsuyoshi H., et al., Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring, J. Neurosci. Res., 2008, 86, 2190-2200
37. Cui K., Ashdown H., Luheshi G. N., Boksa P., Effects of prenatal immune activation on hippocampal neurogenesis in the rat, Schizophr. Res., 2009, 113, 288-297
38. Ling Z., Chang Q. A., Tong C. W., Leurgans S. E., Lipton J. W., Carvey P. M., Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally, Exp. Neurol., 2004, 190, 373-383 (Pubitemid 39504993)
39. Ling Z., Gayle D. A., Ma S. Y., Lipton J. W., Tong C. W., Hong J. S., et al., In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain, Mov. Disord., 2002, 17, 116-124 (Pubitemid 36041267)
40. Romero E., Guaza C., Castellano B., Borrell J., Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia, Mol. Psychiatry, 2010, 15, 372-383
41. Snyder-Keller A., Stark P. F., Prenatal inflammatory effects on nigrostriatal development in organotypic cultures, Brain Res., 2008, 1233, 160-167
42. Bakos J., Duncko R., Makatsori A., Pirnik Z., Kiss A., Jezova D., Prenatal immune challenge affects growth, behavior, and brain dopamine in offspring, Ann. NY Acad. Sci., 2004, 1018, 281-287 (Pubitemid 38951417)
43. Meyer U., Nyffeler M., Yee B. K., Knuesel I., Feldon J., Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice, Brain Behav. Immun., 2008, 22, 469-486 (Pubitemid 351451821)
44. Zuckerman L., Rehavi M., Nachman R., Weiner I., Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia, Neuropsychopharmacology, 2003, 28, 1778-1789 (Pubitemid 41070843)
45. Meyer U., Engler A., Weber L., Schedlowski M., Feldon J., Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy, Neuroscience, 2008, 154, 701-709
46. Lante F., Meunier J., Guiramand J., Maurice T., Cavalier M., de Jesus Ferreira M. C., et al., Neurodevelopmental damage after prenatal infection: role of oxidative stress in the fetal brain, Free Radic. Biol. Med., 2007, 42, 1231-1245 (Pubitemid 46437362)
47. Roumier A., Pascual O., Bechade C., Wakselman S., Poncer J. C., Real E., et al., Prenatal activation of microglia induces delayed impairment of glutamatergic synaptic function, PLoS One, 2008, 3, e2595
48. Lante F., Meunier J., Guiramand J., De Jesus Ferreira M. C., Cambonie G., Aimar R., et al., Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation, Hippocampus, 2008, 18, 602-609 (Pubitemid 351832747)
49. Wang S., Yan J. Y., Lo Y. K., Carvey P. M., Ling Z., Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide, Brain Res., 2009, 1265, 196-204
50. Fatemi S. H., Reutiman T. J., Folsom T. D., Huang H., Oishi K., Mori S., et al., Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders, Schizophr. Res., 2008, 99, 56-70
51. Winter C., Djodari-Irani A., Sohr R., Morgenstern R., Feldon J., Juckel G., et al., Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia, Int. J. Neuropsychopharmacol., 2009, 12, 513-524
52. Winter C., Reutiman T. J., Folsom T. D., Sohr R., Wolf R. J., Juckel G., et al., Dopamine and serotonin levels following prenatal viral infection in mouse - implications for psychiatric disorders such as schizophrenia and autism, Eur. Neuropsychopharmacol., 2008, 18, 712-716
53. Ducharme G., Lowe G. C., Goutagny R., Williams S., Early alterations in hippocampal circuitry and theta rhythm generation in a mouse model of prenatal infection: implications for schizophrenia, PLoS One, 2012, 7, e29754
54. Nyffeler M., Meyer U., Yee B. K., Feldon J., Knuesel I., Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia, Neuroscience, 2006, 143, 51-62 (Pubitemid 44667305)
55. Zuckerman L., Weiner I., Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring, J. Psychiatr. Res., 2005, 39, 311-323 (Pubitemid 40255916)
56. Deverman B. E., Patterson P. H., Cytokines and CNS development, Neuron, 2009, 64, 61-78
57. Boulanger L. M., Immune proteins in brain development and synaptic plasticity, Neuron, 2009, 64, 93-109
58. Borrell V., Marin O., Meninges control tangential migration of hem-derived Cajal-Retzius cells via CXCL12/CXCR4 signaling, Nat. Neurosci., 2006, 9, 1284-1293 (Pubitemid 44454270)
59. Bagri A., Gurney T., He X., Zou Y. R., Littman D. R., Tessier-Lavigne M., et al., The chemokine SDF1 regulates migration of dentate granule cells, Development, 2002, 129, 4249-4260
60. Stumm R., Hollt V., CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: implications for neuronal regeneration in the adult brain, J. Mol. Endocrinol., 2007, 38, 377-382 (Pubitemid 46723253)
61. Stellwagen D., Malenka R. C., Synaptic scaling mediated by glial TNFalpha, Nature, 2006, 440, 1054-1059
62. Beattie E. C., Stellwagen D., Morishita W., Bresnahan J. C., Ha B. K., Von Zastrow M., et al., Control of synaptic strength by glial TNFalpha, Science, 2002, 295, 2282-2285 (Pubitemid 34258846)
63. Stevens B., Allen N. J., Vazquez L. E., Howell G. R., Christopherson K. S., Nouri N., et al., The classical complement cascade mediates CNS synapse elimination, Cell, 2007, 131, 1164-1178 (Pubitemid 350235022)
64. Huh G. S., Boulanger L. M., Du H., Riquelme P. A., Brotz T. M., Shatz C. J., Functional requirement for class I MHC in CNS development and plasticity, Science, 2000, 290, 2155-2159 (Pubitemid 32001597)
65. Hsiao E. Y., Patterson P. H., Activation of the maternal immune system induces endocrine changes in the placenta via IL-6, Brain Behav. Immun., 2011, 25, 604-615
66. Clarke M. C., Tanskanen A., Huttunen M., Whittaker J. C., Cannon M., Evidence for an interaction between familial liability and prenatal exposure to infection in the causation of schizophrenia, Am. J. Psychiatry, 2009, 166, 1025-1030
67. Abazyan B., Nomura J., Kannan G., Ishizuka K., Tamashiro K. L., Nucifora F., et al., Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology, Biol. Psychiatry, 2010, 68, 1172-1181
68. Vuillermot S., Joodmardi E., Perlmann T., Ogren S. O., Feldon J., Meyer U., Prenatal immune activation interacts with genetic Nurr1 deficiency in the development of attentional impairments, J. Neurosci., 2012, 32, 436-451
69. Schizophrenia Psychiatric Genome-Wide Association Study C., Genome-wide association study identifies five new schizophrenia loci, Nat. Genet., 2011, 43, 969-976
70. Bocchio Chiavetto L., Boin F., Zanardini R., Popoli M., Michelato A., Bignotti S., et al., Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia, Biol. Psychiatry, 2002, 51, 480-484 (Pubitemid 34260969)
71. Schwarz M. J., Kronig H., Riedel M., Dehning S., Douhet A., Spellmann I., et al., IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia, Eur. Arch. Psychiatry Clin. Neurosci., 2006, 256, 72-76
72. Yu L., Yang M. S., Zhao J., Shi Y. Y., Zhao X. Z., Yang J. D., et al., An association between polymorphisms of the interleukin-10 gene promoter and schizophrenia in the Chinese population, Schizophr. Res., 2004, 71, 179-183 (Pubitemid 39209487)
73. Chen X., Kendler K. S., Interleukin 3 and schizophrenia, Am. J. Psychiatry, 2008, 165, 13-14 (Pubitemid 351704545)
74. Paul-Samojedny M., Kowalczyk M., Suchanek R., Owczarek A., Fila- Danilow A., Szczygiel A., et al., Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia - a case-control study, J. Mol. Neurosci., 2010, 42, 112-119